Cargando…

Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus

Background: Influenza vaccines are the main tool to prevent morbidity and mortality of the disease; however, egg adaptations associated with the choice of the manufacturing process may reduce their effectiveness. This study aimed to estimate the impact of egg adaptations and antigenic drift on the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz de Lejarazu-Leonardo, Raul, Montomoli, Emanuele, Wojcik, Radek, Christopher, Solomon, Mosnier, Anne, Pariani, Elena, Trilla Garcia, Antoni, Fickenscher, Helmut, Gärtner, Barbara C., Jandhyala, Ravi, Zambon, Maria, Moore, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621612/
https://www.ncbi.nlm.nih.gov/pubmed/34835186
http://dx.doi.org/10.3390/vaccines9111255
_version_ 1784605502039130112
author Ortiz de Lejarazu-Leonardo, Raul
Montomoli, Emanuele
Wojcik, Radek
Christopher, Solomon
Mosnier, Anne
Pariani, Elena
Trilla Garcia, Antoni
Fickenscher, Helmut
Gärtner, Barbara C.
Jandhyala, Ravi
Zambon, Maria
Moore, Catherine
author_facet Ortiz de Lejarazu-Leonardo, Raul
Montomoli, Emanuele
Wojcik, Radek
Christopher, Solomon
Mosnier, Anne
Pariani, Elena
Trilla Garcia, Antoni
Fickenscher, Helmut
Gärtner, Barbara C.
Jandhyala, Ravi
Zambon, Maria
Moore, Catherine
author_sort Ortiz de Lejarazu-Leonardo, Raul
collection PubMed
description Background: Influenza vaccines are the main tool to prevent morbidity and mortality of the disease; however, egg adaptations associated with the choice of the manufacturing process may reduce their effectiveness. This study aimed to estimate the impact of egg adaptations and antigenic drift on the effectiveness of trivalent (TIV) and quadrivalent (QIV) influenza vaccines. Methods: Nine experts in influenza virology were recruited into a Delphi-style exercise. In the first round, the experts were asked to answer questions on the impact of antigenic drift and egg adaptations on vaccine match (VM) and influenza vaccine effectiveness (IVE). In the second round, the experts were presented with the data from a systematic literature review on the same subject and aggregated experts’ responses to round one questions. The experts were asked to review and confirm or amend their responses before the final summary statistics were calculated. Results: The experts estimated that, across Europe, the egg adaptations reduce, on average, VM to circulating viruses by 7–21% and reduce IVE by 4–16%. According to the experts, antigenic drift results in a similar impact on VM (8–24%) and IVE (5–20%). The highest reduction in IVE was estimated for the influenza virus A(H3N2) subtype for the under 65 age group. When asked about the frequency of the phenomena, the experts indicated that, on average, between the 2014 and 19 seasons, egg adaptation and antigenic drift were significant enough to impact IVE that occurred in two and three out of five seasons, respectively. They also agreed that this pattern is likely to reoccur in future seasons. Conclusions: Expert estimates suggest there is a potential for 9% on average (weighted average of “All strains” over three age groups adjusted by population size) and up to a 16% increase in IVE (against A(H3N2), the <65 age group) if egg adaptations that arise when employing the traditional egg-based manufacturing process are avoided.
format Online
Article
Text
id pubmed-8621612
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86216122021-11-27 Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus Ortiz de Lejarazu-Leonardo, Raul Montomoli, Emanuele Wojcik, Radek Christopher, Solomon Mosnier, Anne Pariani, Elena Trilla Garcia, Antoni Fickenscher, Helmut Gärtner, Barbara C. Jandhyala, Ravi Zambon, Maria Moore, Catherine Vaccines (Basel) Review Background: Influenza vaccines are the main tool to prevent morbidity and mortality of the disease; however, egg adaptations associated with the choice of the manufacturing process may reduce their effectiveness. This study aimed to estimate the impact of egg adaptations and antigenic drift on the effectiveness of trivalent (TIV) and quadrivalent (QIV) influenza vaccines. Methods: Nine experts in influenza virology were recruited into a Delphi-style exercise. In the first round, the experts were asked to answer questions on the impact of antigenic drift and egg adaptations on vaccine match (VM) and influenza vaccine effectiveness (IVE). In the second round, the experts were presented with the data from a systematic literature review on the same subject and aggregated experts’ responses to round one questions. The experts were asked to review and confirm or amend their responses before the final summary statistics were calculated. Results: The experts estimated that, across Europe, the egg adaptations reduce, on average, VM to circulating viruses by 7–21% and reduce IVE by 4–16%. According to the experts, antigenic drift results in a similar impact on VM (8–24%) and IVE (5–20%). The highest reduction in IVE was estimated for the influenza virus A(H3N2) subtype for the under 65 age group. When asked about the frequency of the phenomena, the experts indicated that, on average, between the 2014 and 19 seasons, egg adaptation and antigenic drift were significant enough to impact IVE that occurred in two and three out of five seasons, respectively. They also agreed that this pattern is likely to reoccur in future seasons. Conclusions: Expert estimates suggest there is a potential for 9% on average (weighted average of “All strains” over three age groups adjusted by population size) and up to a 16% increase in IVE (against A(H3N2), the <65 age group) if egg adaptations that arise when employing the traditional egg-based manufacturing process are avoided. MDPI 2021-10-29 /pmc/articles/PMC8621612/ /pubmed/34835186 http://dx.doi.org/10.3390/vaccines9111255 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ortiz de Lejarazu-Leonardo, Raul
Montomoli, Emanuele
Wojcik, Radek
Christopher, Solomon
Mosnier, Anne
Pariani, Elena
Trilla Garcia, Antoni
Fickenscher, Helmut
Gärtner, Barbara C.
Jandhyala, Ravi
Zambon, Maria
Moore, Catherine
Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus
title Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus
title_full Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus
title_fullStr Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus
title_full_unstemmed Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus
title_short Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus
title_sort estimation of reduction in influenza vaccine effectiveness due to egg-adaptation changes—systematic literature review and expert consensus
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621612/
https://www.ncbi.nlm.nih.gov/pubmed/34835186
http://dx.doi.org/10.3390/vaccines9111255
work_keys_str_mv AT ortizdelejarazuleonardoraul estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT montomoliemanuele estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT wojcikradek estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT christophersolomon estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT mosnieranne estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT parianielena estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT trillagarciaantoni estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT fickenscherhelmut estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT gartnerbarbarac estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT jandhyalaravi estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT zambonmaria estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus
AT moorecatherine estimationofreductionininfluenzavaccineeffectivenessduetoeggadaptationchangessystematicliteraturereviewandexpertconsensus